Correlation Between Reviva Pharmaceuticals and Entera Bio
Can any of the company-specific risk be diversified away by investing in both Reviva Pharmaceuticals and Entera Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reviva Pharmaceuticals and Entera Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Reviva Pharmaceuticals Holdings and Entera Bio, you can compare the effects of market volatilities on Reviva Pharmaceuticals and Entera Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reviva Pharmaceuticals with a short position of Entera Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reviva Pharmaceuticals and Entera Bio.
Diversification Opportunities for Reviva Pharmaceuticals and Entera Bio
-0.03 | Correlation Coefficient |
Good diversification
The 3 months correlation between Reviva and Entera is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Reviva Pharmaceuticals Holding and Entera Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entera Bio and Reviva Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reviva Pharmaceuticals Holdings are associated (or correlated) with Entera Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entera Bio has no effect on the direction of Reviva Pharmaceuticals i.e., Reviva Pharmaceuticals and Entera Bio go up and down completely randomly.
Pair Corralation between Reviva Pharmaceuticals and Entera Bio
If you would invest 23.00 in Reviva Pharmaceuticals Holdings on August 28, 2024 and sell it today you would lose (2.00) from holding Reviva Pharmaceuticals Holdings or give up 8.7% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 0.8% |
| Values | Daily Returns |
Reviva Pharmaceuticals Holding vs. Entera Bio
Performance |
| Timeline |
| Reviva Pharmaceuticals |
| Entera Bio |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Reviva Pharmaceuticals and Entera Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Reviva Pharmaceuticals and Entera Bio
The main advantage of trading using opposite Reviva Pharmaceuticals and Entera Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reviva Pharmaceuticals position performs unexpectedly, Entera Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entera Bio will offset losses from the drop in Entera Bio's long position.| Reviva Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Reviva Pharmaceuticals vs. CannBioRx Life Sciences | Reviva Pharmaceuticals vs. Clene Inc | Reviva Pharmaceuticals vs. Lixte Biotechnology Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |